documents: FDA-2025-N-1243-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2025-N-1243-0001 | FDA | FDA-2025-N-1243 | Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product | Proposed Rule | Request for Comment | 2025-06-11T04:00:00Z | 2025 | 6 | 2025-06-11T04:00:00Z | 2025-08-12T03:59:59Z | 2025-08-12T09:00:21Z | 2025-10549 | 0 | 0 | 09000064b8ded24e |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref